Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T, Jones SE, Alvarez I, Bertelli G, Ortmann O, Coates AS, Bajetta E, Dodwell D, Coleman RE, Fallowfield LJ, Mickiewicz E, Andersen J, Lønning PE, Cocconi G, Stewart A, Stuart N, Snowdon CF, Carpentieri M, Massimini G, Bliss JM, van de Velde C; Intergroup Exemestane Study..

N Engl J Med. 2004 Mar 11;350(11):1081-92. Erratum in: N Engl J Med. 2004 Dec 2;351(23):2461. N Engl J Med. 2006 Oct 19;355(16):1746. van de Velde, Cornelius [added].

2.
3.

Influences of ethnicity, treatment, and comorbidity on breast cancer survival in Hawaii.

Maskarinec G, Pagano IS, Yamashiro G, Issell BF.

J Clin Epidemiol. 2003 Jul;56(7):678-85.

PMID:
12921937
4.

Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies.

Jellema A, Zeegers MP, Feskens EJ, Dagnelie PC, Mensink RP.

Diabetologia. 2003 Jul;46(7):990-5.

PMID:
12819898
5.

Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.

Hamelers IH, Steenbergh PH.

Endocr Relat Cancer. 2003 Jun;10(2):331-45. Review.

6.

Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland.

Lee AV, Zhang P, Ivanova M, Bonnette S, Oesterreich S, Rosen JM, Grimm S, Hovey RC, Vonderhaar BK, Kahn CR, Torres D, George J, Mohsin S, Allred DC, Hadsell DL.

Endocrinology. 2003 Jun;144(6):2683-94.

PMID:
12746333
7.

Adiposity and sex hormones in postmenopausal breast cancer survivors.

McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R.

J Clin Oncol. 2003 May 15;21(10):1961-6.

8.

Racial differences in genetic factors associated with breast cancer.

Ademuyiwa FO, Olopade OI.

Cancer Metastasis Rev. 2003 Mar;22(1):47-53. Review.

PMID:
12716036
9.

Socioeconomic status and breast carcinoma survival in four racial/ethnic groups: a population-based study.

O'Malley CD, Le GM, Glaser SL, Shema SJ, West DW.

Cancer. 2003 Mar 1;97(5):1303-11.

10.

Intima media thickness of carotid arteries is reduced in heterozygous carriers of the Gly972Arg variant in the insulin receptor substrate-1 gene.

Hölzl B, Iglseder B, Stadlmayr A, Hedegger M, Moré E, Reiter R, Sandhofer F, Paulweber B.

Eur J Clin Invest. 2003 Feb;33(2):110-6.

PMID:
12588284
11.

Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications.

Chang Q, Li Y, White MF, Fletcher JA, Xiao S.

Cancer Res. 2002 Nov 1;62(21):6035-8.

12.

Prevalence and trends in overweight among US children and adolescents, 1999-2000.

Ogden CL, Flegal KM, Carroll MD, Johnson CL.

JAMA. 2002 Oct 9;288(14):1728-32.

PMID:
12365956
13.

Upper abdominal obesity, insulin resistance and breast cancer risk.

Stoll BA.

Int J Obes Relat Metab Disord. 2002 Jun;26(6):747-53. Review.

PMID:
12037643
14.

The Gly972Arg polymorphism in insulin receptor substrate-1 is associated with decreased birth weight in a population-based sample of Brazilian newborns.

Bezerra RM, de Castro V, Sales T, Passini R Jr, Marba ST, Saad ST, Saad MJ.

Diabetes Care. 2002 Mar;25(3):550-3.

PMID:
11874945
15.

IRS-1 Gly971Arg variant is not a new risk factor for coronary artery disease in the Taiwanese population.

Tsai CT, Hwang JJ, Lai LP, Chiang FT, Tseng YZ.

Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):194. No abstract available.

16.

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N.

J Clin Oncol. 2002 Jan 1;20(1):42-51.

PMID:
11773152
17.

Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells.

Mauro L, Salerno M, Panno ML, Bellizzi D, Sisci D, Miglietta A, Surmacz E, Andò S.

Biochem Biophys Res Commun. 2001 Nov 2;288(3):685-9. Erratum in: Biochem Biophys Res Commun 2001 Nov 30;289(2):641.

PMID:
11676497
18.

Defects of the insulin receptor substrate (IRS) system in human metabolic disorders.

Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R.

FASEB J. 2001 Oct;15(12):2099-111. Review.

PMID:
11641236
19.

Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome.

El Mkadem SA, Lautier C, Macari F, Molinari N, Lefèbvre P, Renard E, Gris JC, Cros G, Daurès JP, Bringer J, White MF, Grigorescu F.

Diabetes. 2001 Sep;50(9):2164-8.

Items per page

Supplemental Content

Support Center